United States securities and exchange commission logo




                                                                                
                               April 24, 2024

       Lucy Rutishauser
       Chief Financial Officer
       Sinclair, Inc.
       10706 Beaver Dam Road
       Hunt Valley , MD 21030

                                                        Re: Sinclair, Inc.
                                                            Form 10-K for the 
Fiscal Year Ended December 31, 2023
                                                            Form 8-K filed 
February 28, 2024
                                                            File No. 333-271072

       Dear Lucy Rutishauser:

                                                        We have reviewed your 
filing and have the following comments.

              Please respond to this letter within ten business days by 
providing the requested
       information or advise us as soon as possible when you will respond. If 
you do not believe a
       comment applies to your facts and circumstances, please tell us why in 
your response.

                                                        After reviewing your 
response to this letter, we may have additional comments.

       Form 10-K for the Fiscal Year Ended December 31, 2023

       Management's Discussion and Analysis of Financial Conditions and Results 
of Operations
       Sinclair, Inc. Results of Operations
       Local Media Segment
       Revenues, page 57

   1.                                                   You disclose that 
"Distributors for our broadcast signals, decreased $40 million in 2023,
                                                        when compared to the 
same period in 2022, primarily due to a decrease in subscribers,
                                                        partially offset by an 
increase in contractual rates." Since subscribers and contractual rates
                                                        are the drivers of your 
revenue, please disclose those key statistical measures in your
                                                        MD&A for all periods 
presented. We refer to guidance in Item 303 of Regulation S-K.
   2.                                                   We note you discuss 
local advertising revenue by categories such as political, automotive,
                                                        retail, home products, 
pharma, food, etc. in your earnings presentation. To help investors
                                                        understand the drivers 
of your local advertising revenue, please consider
                                                        disclosing revenue by 
these different categories in future filings for all periods presented.
                                                        Provide us with your 
proposed future disclosure.
 Lucy Rutishauser
FirstName   LastNameLucy Rutishauser
Sinclair, Inc.
Comapany
April       NameSinclair, Inc.
       24, 2024
April 224, 2024 Page 2
Page
FirstName LastName
Notes to the Consolidated Financial Statements
5. Goodwill, Indefinite-lived intangible assets, and other intangible assets, 
page F-23

3.       We note the value of your goodwill significantly exceeds your market
         capitalization. Please provide us with a reconciliation of the 
aggregate fair value of your
         reporting units to your market capitalization as of or around the 
goodwill impairment test
         date. Refer to ASC 350-20-35-22 to 35-24. In future filings if 
goodwill continues to
         exceed your market capitalization, provide a discussion of how you 
considered market
         capitalization when performing your goodwill impairment analysis.
12. Income Taxes, page F-34

4.       We note that in 2022 you increased your valuation allowance by $56 
million and then in
         2023 you decreased it by $212 million. Both the increase and decrease 
in the valuation
         allowance were associated with the federal interest expense 
carryforwards under IRC
         Section 163(j). With a view towards expanded disclosure, please tell 
us specifically what
         occurred in relation to the federal interest expense carryforward 
under IRC Section
         163(j) between 2022 and 2023 that caused the significant change in the 
valuation
         allowance.
Form 8-K filed February 28, 2024

Exhibit 99.1, page 1

5.       We note your statement that "As of December 31, 2023, the Company 
estimated the fair
         market value of Ventures' minority investment portfolio, which 
includes Ventures' cash of
         $343 million, and investments in real estate, private equity, and 
venture capital funds, as
         well as direct investments in companies, at approximately $1.2 
billion, or approximately
         $18 per share." Please tell us specific information about Ventures' 
minority investment
         portfolio and how it is reflected in your Form 10-K for the fiscal 
year ended December 31,
         2023. Disclose how these balances were calculated and why you believe 
it is appropriate
         to present them in your Form 8-K. As applicable, refer to your basis 
in accounting
         literature.
6.       We note that you have disclosed a number of measures labeled as 
"excluding
         Adjustments" or as "excluding DSG." As these amounts appear to be 
non-GAAP
         measures, please revise to identify them as such and to provide the 
disclosures required by
         Item 10(e)(1)(i) of Regulation S-K.
7.       You present the non-GAAP measures Adjusted EBITDA and Adjusted Free 
Cash Flow
         within a tabular disclosure of segment financial information. Please 
explain your basis for
         the manner in which Adjusted EBITDA and Adjusted Cash Flow are 
calculated as part of
         this table (including the consolidated amounts). In addition, tell us 
how you considered
         disclosing Operating income (loss), which is used to measure segment 
performance, with
         equal or greater prominence to the non-GAAP segment measures. Refer to 
Item
 Lucy Rutishauser
FirstName   LastNameLucy Rutishauser
Sinclair, Inc.
Comapany
April       NameSinclair, Inc.
       24, 2024
April 324, 2024 Page 3
Page
FirstName LastName
         10(e)(1)(i)(A) of Regulation S-K and question 102.10(a) of the 
non-GAAP C&DIs.

8.       You state that the "Company considers Adjusted EBITDA to be an 
indicator of the
         Company's operating performance and the ability to service its debt. 
The Company also
         believes that Adjusted EBITDA is frequently used by industry analysts, 
investors and
         lenders as a measure of valuation and ability to service its debt." 
Please clarify whether
         Adjusted EBITDA is a performance measure or a liquidity measure. If it 
is a performance
         measure, explain why there appear to be cash-based adjustments. 
Alternatively, if
         Adjusted EBITDA is a liquidity measure, revise to reconcile it to cash 
provided by
         operating activities as the most directly comparable GAAP-basis 
measure. Please provide
         us with the proposed revised disclosures you intend to include in 
future filings. Refer to
         Item 10(e)(1)(i) of Regulation S-K. In addition, provide us with 
additional detail regarding
         the adjustment for non-recurring transaction, implementation, legal, 
regulatory and other
         costs.
9.       You state that Adjusted Free Cash Flow is used as    an indicator of 
the Company   s
         operating performance,    but it has a label that suggests it is a 
liquidity measure. Please
         revise to clarify the nature of this measure and, if it is a liquidity 
measure, better explain
         how it provides useful information to investors and provide a 
reconciliation to cash
         provided by operating activities. Alternatively, if it is a 
performance measure, tell us how
         you determined it is appropriate to call it Adjusted Free Cash Flow 
and explain why there
         appear to be cash-based adjustments. Please provide us with the 
proposed revised
         disclosures you intend to include in future filings. Refer to Item 
10(e)(1)(i) of Regulation
         S-K and Question 100.05 of the non-GAAP C&DIs. With your response, 
please also
         address your presentation of Adjusted Free Cash Flow on a segment 
basis.
10.      We note your disclosure of Adjusted EBITDA and Adjusted Free Cash Flow 
based on the
         results you expect to achieve for the three months ending March 31, 
2024. We also note
         the statement that you do not provide reconciliations on a 
forward-looking basis. Tell us
         how you determined that the calculations provided are appropriate and 
explain how your
         presentation is consistent with Item 10(e)(1)(i)(B) of Regulation S-K. 
If your are relying
         on the exception provided by Item 10(e)(1)(i)(B) of Regulation S-K, 
provide the reason
         such reconciliation has not been provided, the information that is not 
available, and the
         significance of that information. Refer to Question 102.10(b) of the 
non-GAAP C&DIs.
11.      Please tell us how your reconciliation of GAAP Operating Income to 
Adjusted EBITDA
         on a consolidated basis is consistent with the requirement per Item 
10(e)(1)(i)(B) of
         Regulation S-K to reconcile non-GAAP measures to the most directly 
comparable GAAP-
         basis measure.
        We remind you that the company and its management are responsible for 
the accuracy
and adequacy of their disclosures, notwithstanding any review, comments, action 
or absence of
action by the staff.
 Lucy Rutishauser
Sinclair, Inc.
April 24, 2024
Page 4

       Please contact Inessa Kessman at 202-551-3371 or Robert Littlepage at 
202-551-3361 if
you have questions regarding comments on the financial statements and related 
matters.



FirstName LastNameLucy Rutishauser                       Sincerely,
Comapany NameSinclair, Inc.
                                                         Division of 
Corporation Finance
April 24, 2024 Page 4                                    Office of Technology
FirstName LastName